|
EIF2C2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.357700E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.100800E-03 |
| Normal-vs-Stage2 |
8.813000E-01 |
| Normal-vs-Stage3 |
9.000200E-01 |
| Normal-vs-Stage4 |
9.020600E-01 |
| Stage1-vs-Stage2 |
1.825550E-02 |
| Stage1-vs-Stage3 |
7.715300E-03 |
| Stage1-vs-Stage4 |
4.232300E-02 |
| Stage2-vs-Stage3 |
9.701400E-01 |
| Stage2-vs-Stage4 |
8.281800E-01 |
| Stage3-vs-Stage4 |
8.284400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.137000E-01 |
| Normal-vs-AfricanAmerican |
7.776400E-01 |
| Normal-vs-Asian |
2.255800E-01 |
| Caucasian-vs-AfricanAmerican |
5.217000E-01 |
| Caucasian-vs-Asian |
3.064200E-01 |
| AfricanAmerican-vs-Asian |
2.579000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.868850E-01 |
| Normal-vs-Female |
7.979800E-02 |
| Male-vs-Female |
4.971200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.281200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.147920E-02 |
| Normal-vs-Age(61-80Yrs) |
5.380200E-01 |
| Normal-vs-Age(81-100Yrs) |
6.810200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.804400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.484000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.987800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.986400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.482610E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.180000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.000560E-01 |
| Normal-vs-Grade 2 |
1.057650E-02 |
| Normal-vs-Grade 3 |
9.658200E-01 |
| Normal-vs-Grade 4 |
5.374000E-01 |
| Grade 1-vs-Grade 2 |
4.804000E-01 |
| Grade 1-vs-Grade 3 |
4.077700E-02 |
| Grade 1-vs-Grade 4 |
2.738200E-01 |
| Grade 2-vs-Grade 3 |
5.682600E-03 |
| Grade 2-vs-Grade 4 |
2.724400E-01 |
| Grade 3-vs-Grade 4 |
5.395400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.789840E-02 |
| Normal-vs-ccB subtype |
6.383700E-02 |
| ccA subtype-vs-ccB subtype |
8.273200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.159000E-01 |
| Normal-vs-N1 |
9.850400E-01 |
| N0-vs-N1 |
7.668000E-01 |
|
|
